The US food and drug administration perspective on cancer biomarker development

被引：141
|
作者：
Gutman, Steven
Kessler, Larry G.
机构：
[1] US FDA, Off In Vitro Diagnost Devices, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA
[2] US FDA, Off Sci, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA
[3] US FDA, Engn Labs, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA
来源：
NATURE REVIEWS CANCER | 2006年 / 6卷 / 07期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1038/nrc1911
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Despite the intense interest in biomarker development for cancer management, few biomarker assays for diagnostic uses have been submitted to the US Food and Drug Administration (FDA). What challenges must researchers overcome to bring cancer-detection technologies to the market and, therefore, into clinical use?
引用
收藏
页码：565 / 571
页数：8
相关论文
共 50 条
  • [21] Clinical Evidence Supporting Pharmacogenomic Biomarker Testing Provided in US Food and Drug Administration Drug Labels
    Wang, Bo
    Canestaro, William J.
    Choudhry, Niteesh K.
    JAMA INTERNAL MEDICINE, 2014, 174 (12) : 1938 - 1944
  • [22] US Food and Drug Administration Updates
    Sahin, L.
    BIRTH DEFECTS RESEARCH, 2018, 110 (09): : 748 - 748
  • [23] Urokinase and the US food and drug administration
    Ouriel, K
    JOURNAL OF VASCULAR SURGERY, 1999, 30 (05) : 957 - 958
  • [24] Independence at the US Food and Drug Administration
    不详
    LANCET, 2006, 367 (9523): : 1630 - 1630
  • [25] Transparency at the US Food and Drug Administration
    Califf, Robert M.
    JOURNAL OF LAW MEDICINE & ETHICS, 2017, 45 : 24 - 28
  • [26] Developmental therapeutics in childhood cancer - A perspective from the Children's Oncology Group and the US Food and Drug Administration
    Bernstein, ML
    Reaman, GH
    Hirschfeld, S
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2001, 15 (04) : 631 - +
  • [27] Oncology Drug Development and Approval of Systemic Anticancer Therapy by the US Food and Drug Administration
    Martell, Robert E.
    Sermer, David
    Getz, Kenneth
    Kaitin, Kenneth I.
    ONCOLOGIST, 2013, 18 (01): : 104 - 111
  • [28] US Food and Drug Administration Approval Overview in Metastatic Breast Cancer
    Cortazar, Patricia
    Justice, Robert
    Johnson, John
    Sridhara, Rajeshwari
    Keegan, Patricia
    Pazdur, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (14) : 1705 - 1711
  • [29] Single-arm trials for US Food and Drug Administration cancer drug approvals
    Nierengarten, Mary Beth
    CANCER, 2023, 129 (11) : 1626 - 1627
  • [30] Integrated Drug Reviews at the US Food and Drug Administration
    Woodcock, Janet
    Stein, Peter
    Bugin, Kevin
    JAMA INTERNAL MEDICINE, 2020, 180 (09) : 1248 - 1250
12345